omega-n-methylarginine has been researched along with transforming growth factor alpha in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (transforming growth factor alpha) | Trials (transforming growth factor alpha) | Recent Studies (post-2010) (transforming growth factor alpha) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 4,301 | 44 | 623 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gandhi, CR; Uemura, T | 1 |
1 other study(ies) available for omega-n-methylarginine and transforming growth factor alpha
| Article | Year |
|---|---|
Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent.
Topics: Animals; Antibodies, Monoclonal; Cells, Cultured; Culture Media, Conditioned; DNA; Dose-Response Relationship, Drug; Endotoxins; Gene Expression Regulation, Enzymologic; Hepatocytes; Interleukin-1; Interleukin-6; Lipopolysaccharides; Liver; Male; Neutralization Tests; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor alpha; Transforming Growth Factor beta | 2001 |